Acute psychotic disorders related to bupropion: Review of the literature;Troubles psychotiques aigus liés au bupropion : revue de la littérature

Encephale

Volumn 36, Issue 6, 2010, Pages 461-471

  Javelot, T ^a   Javelot, H ^b   Baratta, A ^c   Weiner, L ^c   Messaoudi, M ^d   Lemoine, P ^e  

^a Centre psychothérapique du Nord Dauphiné   (France)

^b CHU NANCY BRABOIS   (France)

^c Service G06   (France)

^d Laboratoire ETAP   (France)

^e Clinique Lyon Lumiere   (France)

Author keywords

Adverse drug event; Bupropion; Smoking cessation; Substance induced psychosis

Indexed keywords

AMFEBUTAMONE; AMPHETAMINE; BENZODIAZEPINE; DOPAMINE; NICOTINE; NICOTINIC RECEPTOR; NORADRENALIN; PLACEBO;

ACUTE PSYCHOSIS; ARTICLE; AUDITORY HALLUCINATION; CLINICAL FEATURE; DRUG INDUCED DISEASE; DRUG MARKETING; DRUG MECHANISM; DRUG WITHDRAWAL; FRANCE; HUMAN; PARANOIA; SCHIZOAFFECTIVE PSYCHOSIS; SMOKING CESSATION; TOBACCO DEPENDENCE; VISUAL HALLUCINATION;

ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BUPROPION; HUMANS; PSYCHOSES, SUBSTANCE-INDUCED; RISK FACTORS; SMOKING CESSATION;

EID: 78649904056     PISSN: 00137006     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.encep.2010.01.005     Document Type: Article

References (67)

1. J.S. Ahluwalia, K.J. Harris, and D. Catley Sustained-release bupropion for smoking cessation in African Americans: a randomized controlled trial JAMA 288 4 2002 468 474
2. D.A. Ames, W.C. Wirshing, and M.P. Szuba Organic mental disorders associated with bupropion in three patients J Clin Psychiatry 53 2 1992 53 55
3. H.J. Aubin, S. Tiliket, and D. Barrucand Dépression et tabagisme Encéphale 22 1996 17 22
4. J. Bailey, and S. Waters Acute psychosis after bupropion treatment in healthy 28-year-old woman J Am Board Fam Med 21 3 2008 244 245
5. M.G. Belson, and T.R. Kelley Bupropion exposures: clinical manifestations and medical outcome J Emerg Med 23 3 2002 223 230
6. F. Benazzi Severe mania following abrupt nicotine withdrawal Am J Psychiatry 146 12 1989 1641
7. F. Benazzi, and M. Mazzoli Psychotic affective disorder after nicotine withdrawal Am J Psychiatry 151 3 1994 452
8. M.N. Beyens, C. Guy, and G. Mounier Serious adverse reactions of bupropion for smoking cessation, analysis of the french pharmacovigilance database from 2001 to 2004 Drug Saf 31 11 2008 1017 1026
9. Birchall P, Salter A, Quigley A, et al. Clinical guidelines for the management of acute amphetamine psychosis. Office of Mental Health, Department of Health, Drug and Alcohol Office, Government of Western Australia, 2007.
10. D.J. Bond, M.M. Noronha, and M. Kauer-Sant'Anna Antidepressant-associated mood elevations in bipolar II disorder compared with bipolar I and major depressive disorder: a systematic review and meta-analysis J Clin Psychiatry 69 10 2008 1589 1601
11. A. Borgne, H.J. Aubin, and I. Berlin Les stratégies thérapeutiques actuelles du sevrage tabagique Rev Prat 54 2004 1 11
12. G. Can, F. Öztuna, and M. Topbas Complaints related to smoking cessation Tuberk Toraks 55 4 2007 364 369
13. I. Cancelli, G. Marcon, and M. Balestrieri Factors associated with complex visual hallucinations during antidepressant treatment Hum Psychopharmacol Clin Exp 19 2004 577 584
14. C.H. Chan, H.C. Liu, and M.C. Huang Delirium associated with concomitant use of low-dose bupropion sustained-release and fluoxetine J Clin Psychopharmacol 26 6 2006 677 678
15. A. Charuvastra, and D. Yaeger Tactile hallucinations associated with therapeutic doses of bupropion in 2 patients J Clin Psychiatry 67 11 2006 1820 1821
16. L.S. Covey, A.H. Glassman, and F. Stetner Major depression following soking cessation Am J Psychiatry 154 1997 263 265
17. P.S. D'Aquila, M. Collu, and G.L. Gessa The role of dopamine in the mechanism of action of antidepressant drugs Eur J Pharmacol 405 2000 365 373
18. S.R. Dager, and A.J. Heritch A case of bupropion-associated delirium J Clin Psychiatry 51 7 1990 307 308
19. A. Dervaux, and X. Laqueille Tabac et schizophrénie : aspects thérapeutiques Encéphale 33 1 2007 629 632
20. A. Dervaux, and X. Laqueille Tabac et schizophrénie : aspects épidémiologiques et cliniques Encéphale 34 2008 299 305
21. S. Dhillon, P.H.L. Yang, and M.P. Curran Bupropion. A review of its use in the management of major depressive disorder Drugs 68 5 2008 653 689 (Pubitemid 351484811)
22. C.J. Elko, J.L. Burgess, and W.O. Robertson Zolpidem-associated hallucinations and serotonin reuptake inhibition: a possible interaction J Toxicol Clinical Toxicol 36 3 1998 195 203
23. A.E. Evins, C. Cather, and M.A. Culhane A 12-week double-blind, placebo-controlled study of bupropion SR added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia J Clin Psychopharmacol 27 4 2007 380 386
24. A.E. Evins, C. Cather, and T. Deckersbach A double-blind placebo-controlled trial of bupropion sustained-release for smoking cessation in schizophrenia J Clin Psychopharmacol 25 2005 218 225
25. M. Fava, J.A. John Rush, and M.E. Thase 15 years of clinical experience with bupropion HCl: from bupropion to bupropion SR to bupropion XL Prim Care Companion J Clin Psychiatry 7 2005 106 113
26. M.J. Filteau, J. Leblanc, and S. Lefranoixe Visual and auditory hallucinations with the association of bupropion and valproate Can J Psychiatry 45 2 2000 198 199
27. D.L. Fogelson, A. Bystritsky, and R. Pasnau Bupropion in the treatment of bipolar disorders: the same old story? J Clin Psychiatry 53 12 1992 443 446
28. K.F. Foley, K.P. DeSanty, and R.E. Kast Bupropion: pharmacology and therapeutic applications Expert Rev Neurother 6 9 2006 1249 1265
29. R. Gallagher Nicotine withdrawal as an etiologic factor in delirium J Pain Symptom Manage 16 2 1998 76 77
30. T.P. George, J.C. Vessicchio, and K.A. Sacco A placebo-controlled trial of bupropion combined with nicotine patch for smoking cessation in schizophrenia Biol Psychiatry 63 2008 1092 1096
31. T.P. George, J.C. Vessicchio, and A. Termine A placebo controlled trial of bupropion for smoking cessation in schizophrenia Biol Psychiatry 52 2002 53 61
32. R.N. Golden, S.P. James, and M.A. Sherer Psychoses associated with bupropion treatment Am J Psychiatry 142 12 1985 1459 1462
33. D.J. Goode, and A.A. Manning Comparison of bupropion alone and with haloperidol in schizo-affective disorder, depressed type J Clin Psychiatry 44 1983 253 255
34. M. Hahn, T. Hajek, and M. Alda Psychosis induced by low-dose bupropion: sensitization of dopaminergic system by past cocaine abuse? J Psychiatr Pract 13 5 2007 336 338
35. M.A. Hertzberg, S.D. Moore, and M.E. Feldman A Preliminary study of bupropion sustained-release for smoking cessation in patients with chronic posttraumatic stress disorder J Clin Psychopharmacol 21 1 2001 94 98
36. K.J. Holm, and C.M. Spencer Bupropion. A review of its use in the management of smoking cessation Drugs 59 4 2000 1007 1024
37. W.T. Howard, and J.K. Warnock Bupropion-induced psychosis Am J Psychiatry 156 12 1999 2017 2018
38. J.R. Hughes, L.F. Stead, and T. Lancaster Antidepressants for smoking cessation Cochrane Database Syst Rev 1 2007 CD000031
39. C.W. Jackson, L.A. Head, and C.H. Kellner Catatonia associated with bupropion treatment J Clin Psychiatry 53 6 1992 210
40. H. Javelot, A. Baratta, and L. Weiner Two acute psychotic episodes after administration of bupropion: a case of involuntary rechallenge Pharm World Sci 31 2009 238 240
41. J.A. Johnston, C.G. Lineberry, and C.S. Frieden Prevalence of psychosis, delusions and hallucinations in clinical trials with bupropion, Dr Golden and associates reply Am J Psychiatry 143 9 1986 1192 1193
42. T.A. Ketter, J.B. Jenkins, and D.H. Schroeder Carbamazepine but not valproate induces bupropion metabolism J Clin Psychopharmacol 15 5 1995 327 333
43. L.A. Labbate Nicotine cessation, mania and depression Am J Psychiatry 149 5 1992 708
44. G.S. Leverich, L.L. Altshuler, and M.A. Frye Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers Am J Psychiatry 163 2006 232 239
45. I. Liberzon, J.R. Dequardo, and K.R. Silk Bupropion and delirium Am J Psychiatry 147 12 1990 1990
46. C.Y. Liu, and Y.S. Chien Perceptual disturbances associated with low-dose bupropion sustained-release treatment J Clin Psychopharmacol 27 5 2007 543 544
47. S.A. Mayer, J.Y. Chong, and E. Ridgway Delirium from nicotine withdrawal in neuro-ICU patients Neurology 57 2001 551 553
48. M. Neumann, V. Livak, and H.W. Paul Acute psychosis after administration of bupropion hydrochloride (ZYBAN) Pharmacopsychiatry 35 2002 247 248 (Pubitemid 36061317)
49. F. Noble Bupropion : risques et avantages de son utilisation. Que dit la recherche préclinique ? Ann Med Interne 153 s7/2 2002 S37 S41
50. C. Pittenger, C. Naungayan, and S.F. Kendell Visual hallucinations from addition of riluzole to memantine and bupropion J Clin Psychopharmacol 26 2 2006 218 220
51. A.P. Popli, J. Tanquary, and V. Lamparella Bupropion and anticonvulsant drug interactions Ann Clin Psychiatry 7 5 1995 99 101
52. R.M. Post, L.L. Altshuler, and G.S. Leverich Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline Br J Psychiatry 189 2006 124 131
53. S. Potvin, E. Stip, and J.Y. Roy Toxic psychoses as pharmacological models of schizophrenia Curr Psychiatry Rep 1 2005 23 32
54. S. Ross, and D. Williams Bupropion: risks and benefits Expert Opin Drug Saf 4 6 2005 995 1003
55. G.S. Sachs, A.A. Nierenberg, and J.R. Calabrese Effectiveness of adjunctive antidepressant treatment for bipolar depression N Engl J Med 356 17 2007 1711 1722
56. G. Shepherd, L.I. Velez, and D.C. Keyes Intentional bupropion overdoses J Emerg Med 27 2 2004 147 151
57. G. Shepherd Adverse effects associated with extra-doses of bupropion Pharmacotherapy 25 10 2005 1378 1382
58. S. Shiffman, J.A. Johnston, and M. Khayrallah The effect of bupropion on nicotine craving and withdrawal Psychopharmacology 148 2000 33 40
59. S.J. Shoptaw, U. Kao, and W.W. Ling Treatment for amphetamine psychosis Cochrane Database Syst Rev 4 2008 CD003026
60. A.L. Stoll, P.V. Mayer, and M. Kolbrener Antidepressant-associated mania: a controlled comparison with spontaneous mania Am J Psychiatry 151 11 1994 1642 1645
61. M.E. Thase, and G.S. Sachs Bipolar depression: pharmacotherapy and related therapeutic strategies Biol Psychiatry 48 2000 558 572
62. S. Tonstad Use of sustained-release bupropion in specific patient populations for smoking cessation Drugs 62 Suppl. 2 2002 37 43
63. D. Tran-Van, Y. Hervé, and P. Labadie Agitation en réanimation : penser au syndrome de sevrage nicotinique Ann Fr Anesth Reanim 23 2004 604 606
64. J.Y. Tsoh, G.L. Humfleet, and R.F. Munoz Development of major depression after treatment for smoking cessation Am J Psychiatry 157 2000 368 374
65. T. Van Putten, and I. Shaffer Delirium associated with bupropion J Clin Psychopharmacol 10 3 1990 234
66. T.S. Wang, I.S. Shiaha, and C.B. Yeha Acute psychosis following sustained release bupropion overdose Prog Neuropsychopharmacol Biol Psychiatry 29 2005 149 151
67. L.N. Yatham, S.H. Kennedy, and C. O'Donovan Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007 Bipolar Disord 8 2006 721 739